Mackenzie Financial Corp trimmed its stake in Herbalife Nutrition Ltd (NYSE:HLF) by 93.7% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,597 shares of the company’s stock after selling 113,203 shares during the period. Mackenzie Financial Corp’s holdings in Herbalife Nutrition were worth $325,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Atria Investments LLC acquired a new stake in Herbalife Nutrition in the 2nd quarter worth $2,592,000. Holocene Advisors LP acquired a new stake in Herbalife Nutrition in the 2nd quarter worth $1,024,000. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in Herbalife Nutrition in the 2nd quarter worth $3,900,000. Banco de Sabadell S.A acquired a new stake in Herbalife Nutrition in the 2nd quarter worth $731,000. Finally, Edgestream Partners L.P. grew its position in Herbalife Nutrition by 632.9% in the 2nd quarter. Edgestream Partners L.P. now owns 377,870 shares of the company’s stock worth $16,158,000 after purchasing an additional 326,313 shares during the last quarter. Institutional investors own 92.97% of the company’s stock.
Shares of Herbalife Nutrition stock opened at $39.05 on Friday. The firm’s 50-day simple moving average is $37.74 and its 200-day simple moving average is $43.18. Herbalife Nutrition Ltd has a twelve month low of $33.62 and a twelve month high of $61.77. The firm has a market cap of $5.91 billion, a P/E ratio of 13.56 and a beta of 0.48.
Several analysts have recently weighed in on the stock. Citigroup decreased their target price on shares of Herbalife Nutrition from $66.00 to $57.00 and set a “buy” rating on the stock in a research report on Friday, August 2nd. ValuEngine upgraded shares of Herbalife Nutrition from a “sell” rating to a “hold” rating in a research report on Thursday, August 1st. Pivotal Research reiterated a “buy” rating and set a $65.00 target price (down from $75.00) on shares of Herbalife Nutrition in a research report on Friday, August 2nd. Zacks Investment Research upgraded shares of Herbalife Nutrition from a “sell” rating to a “hold” rating in a research report on Wednesday, October 2nd. Finally, Pi Financial upgraded shares of Herbalife Nutrition from a “neutral” rating to a “buy” rating and lifted their target price for the company from $8.75 to $12.75 in a research report on Thursday, August 8th. Four analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Herbalife Nutrition currently has a consensus rating of “Buy” and an average price target of $49.25.
Herbalife Nutrition Company Profile
Herbalife Nutrition Ltd. develops and sells nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, and the Asia Pacific. It provides science-based products in the areas of weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition.
Featured Story: Recession
Want to see what other hedge funds are holding HLF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Herbalife Nutrition Ltd (NYSE:HLF).
Receive News & Ratings for Herbalife Nutrition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife Nutrition and related companies with MarketBeat.com's FREE daily email newsletter.